Melasma Matters: From Standard of Care to New Options
July 12, 2018
Joshua Zeichner, MD, FAAD, Seemal R. Desai, MD
Seemal R. Desai, MD talks with host Joshua Zeichner, MD about the importance of addressing dermatologic diseases that affect patients with skin of color in this ever-changing multicultural population. Dr. Desai says the number one issue affecting this population is pigmentary issues, particularly melasma. He reviews advances in the understanding of the pathophysiology of melasma, the role of hydroquinone in treatment, a new off-label treatment, and what may be in the pipeline. He says it's important to note that melasma is not a monotherapy disease and that patients should be made aware that this is a chronic condition that needs life-time management.